Searchable abstracts of presentations at key conferences on calcified tissues

ba0002p15 | (1) | ICCBH2013

Osteogenesis imperfecta-bone mass acquisition under bisphosphonates treatment and additional gain in BMD in time of rhGH treatment for growth delay

Galesanu Corina , Zaharia Valentin , Apostu Luminita

Objectives: Patients with osteogenesis imperfecta (OI) type IA have a mild phenotype with normal or near-normal height. The addition of recombinant human GH (rhGH) to ongoing treatment with bisphosphonates can increase measures of BMD and growth. We studied growth rate bone density and bone metabolism in two girls affected by OI type IA and growth delay.Materials and methods: Eight children (six girls and two boys) with OI type IA were treated with Rised...